Founding Partner & Managing Director, Brandon Capital
| Role | Organisation | Sources |
|---|---|---|
| Founding Partner & Managing Director | Brandon Capital | Forbes Australia, Brandon Capital portfolio, Brandon BioCatalyst portfolio, Startup News (WA), Brandon Capital team page |
Stories naming Dr Stephen Thompson. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Novartis is acquiring London biotech Myricx Bio for US$1.1 billion upfront plus milestone payments, handing Melbourne venture firm Brandon Capital a record return on the startup it seeded in 2019.
Perth medtech OncoRes Medical announced $12.5 million: a $9.5 million Series A2 co-led by Brandon Capital and Australian Unity, plus a $3 million government grant, and hired a new R&D vice president.
Also Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Startup News (WA)